Pearl Therapeutics (Acquired by AstraZeneca)
Biopharmaceutical company that developed inhaled therapies for respiratory diseases including COPD. Acquired by AstraZeneca in 2013 for up to $1.15 billion.
Location
Redwood City, California, USA
Founded
2006
Investors
1
Categories
respiratory, therapeutics, copd, acquired
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| 5AM Ventures | Menlo Park, USA | biotech-focused | seedseries-a+1 | 8 |